Takeda Pharmaceutical Company Limited

Darwin Discovery Limited

Richard John Davenport

Hazel Joan Dyke

Andrew Sharpe

Verity Margaret Sabin

William John Farnaby

Hannah Canning

Susanne Wright

Andrew Douglas Baxter

Alan Findlay Haughan

David Alan Owen

Robert John Watson

George Martin Buckley

Hannah Jayne Kendall

David Harrison

Duncan Batty

Stephen Mack

Gregory Barker

William Buffham

Alka Parmar

John Gary Montana

Christopher Lowe

Natasha Kinsella

David Livermore

Anne Goldby

Kerry Jenkins

Marianna Dilani Richard

Saleh Ahmed

Duncan Hannah

Henriette Willems

Catherine Louise Picken

Robert Downham

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X, X, X, Y, Y, R, Rand Rare as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Compounds

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R, X, m, R, Y, R, Z, n, R, A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Amide derivatives as lysophosphatidic acid receptor antagonists

The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X, XX, X, R, R, Rand Rare as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy. 

3-substituted 2-amino-indole derivatives

Hydroxamic and carboxylic acid derivatives

Heterocyclic compounds and their therapeutic use

Compounds that are inhibitors of phosphodiesterase and have therapeutic utility, are of formula (i)

Benzothiazole compounds and their therapeutic use

Growing community of inventors

Cambridge, United Kingdom

Richard John Davenport